| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.1 | $0-$5k | 0.00 |
Summary
A vulnerability marked as problematic has been reported in Open-Xchange AppSuite up to 7.6.0. Impacted is an unknown function. The manipulation leads to cross site scripting. This vulnerability is referenced as CVE-2014-5234. Remote exploitation of the attack is possible. No exploit is available. It is suggested to upgrade the affected component.
Details
A vulnerability was found in Open-Xchange AppSuite up to 7.6.0 (Groupware Software) and classified as problematic. This issue affects an unknown code. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
Cross-site scripting (XSS) vulnerability in the backend in Open-Xchange (OX) AppSuite before 7.4.2-rev33 and 7.6.x before 7.6.0-rev16 allows remote attackers to inject arbitrary web script or HTML via a folder publication name.
The weakness was published 09/17/2014 by Martin (Website). The advisory is shared at securityfocus.com. The identification of this vulnerability is CVE-2014-5234 since 08/13/2014. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
Upgrading to version 7.2.2 eliminates this vulnerability.
The vulnerability is also documented in the databases at SecurityFocus (BID 69796†) and Secunia (SA61080†). Similar entries are available at VDB-71286 and VDB-73031. If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.open-xchange.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
OpenVAS ID: 863077
OpenVAS Name: Open-Xchange (OX) AppSuite Multiple Vulnerabilities -01 Oct15
OpenVAS File: 🔍
OpenVAS Family: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: AppSuite 7.2.2
Timeline
08/13/2014 🔍09/15/2014 🔍
09/17/2014 🔍
09/17/2014 🔍
03/26/2015 🔍
03/29/2022 🔍
Sources
Vendor: open-xchange.comAdvisory: 128257⛔
Researcher: Martin
Status: Not defined
Confirmation: 🔍
CVE: CVE-2014-5234 (🔍)
GCVE (CVE): GCVE-0-2014-5234
GCVE (VulDB): GCVE-100-71285
SecurityFocus: 69796 - Open-Xchange AppSuite CVE-2014-5234 HTML Injection Vulnerability
Secunia: 61080
See also: 🔍
Entry
Created: 03/26/2015 15:08Updated: 03/29/2022 09:14
Changes: 03/26/2015 15:08 (51), 03/12/2019 20:16 (9), 03/29/2022 09:14 (3)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.